Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |